Answers are grounded in this paper and cite their sources.
The finding of moderate sNfL elevation in patients with long ALS duration underlined the favorable prognosis of low sNfL. The strong correlation of sNfL Z score with ALS-PR strengthened its value as progression marker in clinical management and research. The lowering of sNfL in correlation with long TIV duration could reflect a reduction either in disease activity or in the neuroaxonal substrate of biomarker formation during the protracted course of ALS.
No takes yet. Share an insight, caveat, or question.
Meyer et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: